Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity

NCT03574597 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

17604

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: Semaglutide
DRUG: Placebo (semaglutide)

Sponsor

Novo Nordisk A/S